The 32-page, 11-count complaint and demand for a jury trial was filed on 4/20
Santa Ana-based California cannabis testing lab Cannalysis made big headlines late last year by securing $22.6 million in investments led by its newest buy-in bedfellow, a company called CanLab.
That influx of fresh capital was to allow Cannalysis to expand throughout the state of California and into Oregon, to double the size of their SoCal headquarters, and to finance their advancement of robotics and automation in the cannabis testing field.
Instead, the powers that be at CanLab allegedly used their newly purchased leverage to stage an internal coup against Cannalysis co-Founder and CEO, Brian Lannon, eventually leading to his ouster altogether from the company.
This is the allegation that Lannon and his co-plaintiff (his dad) have made in a court filing dated April 20th of this year, but that’s not all he has to say about his short-lived business partners.
According to Lannon, and the 32-page, 11-count complaint and demand for a jury trial filed on 4/20 by him and his lawyers, the defendants named in the case not only wrongfully terminated him but have since refused to reveal any business financials to him, though he is still a shareholder.
To Read The Rest Of This Article On Beard Bro Pharms, Click Here